Under this metastasis-suppressed condition, combining CypD-based local therapy with immune checkpoint inhibitors or conventional cytotoxic anticancer drugs, already used in clinical melanoma treatment, may enhance overall therapeutic efficacy. Here, PPIF is linked to melanoma.